ONCORUS, INC.

Profile

Company Names

ONCORUS, INC.

Addresses

50 HAMPSHIRE STREET, SUITE 401, CAMBRIDGE, MA 02139

450 KENDALL STREET, 4TH FLOOR, CAMBRIDGE, MA 02142

450 KENDALL STREET, 5TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-425-9200
857-320-6400

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$115,096,580.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-08-05 
$53,761,497.00 
$89,602,491.00 
$35,840,994.00 
Equity 
1
2016-03-31 
$61,335,083.00 
$61,425,089.00 
$90,006.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THEODORE 
 
ASHBURN 
EXECUTIVE OFFICER, DIRECTOR
ONCORUS, INC.
THOMAS 
 
CHALBERG 
EXECUTIVE OFFICER
AVALANCHE BIOTECHNOLOGIES, INC.   |  ONCORUS, INC.
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
MARY KAY 
 
FENTON 
DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  ONCORUS, INC.
MITCHELL 
 
FINER 
EXECUTIVE OFFICER, DIRECTOR
INTRACEL HOLDINGS CORP   |  ADVANTAGENE, INC.   |  ONCORUS, INC.   |  SEMMA THERAPEUTICS, INC.
ROBERT 
 
KIRKMAN 
DIRECTOR
TRILLIUM THERAPEUTICS INC.   |  ONCORUS, INC.   |  MR. MANGO LLC
ALON 
 
LAZARUS 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  ONCORUS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  AURON THERAPEUTICS, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  ENTACT BIO, INC.   |  REUNION NEUROSCIENCE, INC.   |  CROSSBOW THERAPEUTICS, INC.
JOHN 
 
MCCABE 
EXECUTIVE OFFICER
ELEVEN BIOTHERAPEUTICS, INC.   |  ONCORUS, INC.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEWLEOS THERAPEUTICS, INC.
BRIGGS 
 
MORRISON 
DIRECTOR
ONCORUS, INC.   |  RIFT BIOTHERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ARVINAS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  CROSSBOW THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  CHARM THERAPEUTICS INC.
CYRUS 
 
MOZAYENI 
EXECUTIVE OFFICER
ONCORUS, INC.
SPENCER 
 
NAM 
DIRECTOR
KENSINGTON-SV GLOBAL INNOVATIONS LP   |  ONCORUS, INC.   |  KSV PURITY, LLC   |  KSV SATURN, LLC   |  KSV PATTERN, LLC   |  KSV EUROPA, LLC   |  KSV MACHINA, LLC   |  KSV BEAUTY, LLC
CHRISTOPHE 
 
QUEVA 
EXECUTIVE OFFICER
ONCORUS, INC.
MARC 
 
RECHT 
EXECUTIVE OFFICER
ONCORUS, INC.
CAMERON 
 
WHEELER 
DIRECTOR
LUMOS PHARMA, INC.   |  BLADE THERAPEUTICS, INC.   |  ONCORUS, INC.   |  MTRAP INC.   |  RIBON THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  HOMOLOGY MEDICINES, INC.   |  VIBLIOME THERAPEUTICS, LLC   |  FRONTIER MEDICINES CORP   |  NUVALENT, INC.   |  PERCEIVE BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-12-20
D/A
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-05 
2019-08-20
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-05 
2018-09-21
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-11-14
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-08-05
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-04-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#